User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients

Primary tabs

Stralen, Ev Leguit, R. J. Begthel, H. Michaux, Lucienne Buijs, A. Lemmens, Heidi [UCL] Doyen, Chantal [UCL] Pierre, Patrick [UCL] Bast, B. J. E. G.
Document type Article de périodique (Journal article) – Letter, Research Support, Non-U.S. Gov't
Access type Accès restreint
Publication date 2009
Language Anglais
Journal information "Leukemia" - Vol. 23, no. 4, p. 801-3 (2009)
Peer reviewed yes
Publisher Nature Publishing Group (London)
issn 0887-6924
e-issn 1476-5551
Publication status Publié
Affiliations UCL - MD/MINT - Département de médecine interne
UCL - (MGD) Service d'hématologie
UCL - MD/MIGE - Département de microbiologie, d'immunologie et de génétique
UCL - (SLuc) Service de biologie hématologique
MESH Subject Tumor Markers, Biological ; Translocation, Genetic ; Prognosis ; Oncogene Proteins - analysis ; Multiple Myeloma - diagnosis - genetics ; Middle Aged ; Male ; MafB Transcription Factor - analysis ; Immunohistochemistry ; Humans ; Female ; Chromosomes, Human, Pair 20 ; Chromosomes, Human, Pair 14
Links
  1. Chang Hong, Qi Q, Xu W, Patterson B, c-Maf nuclear oncoprotein is frequently expressed in multiple myeloma, 10.1038/sj.leu.2404669
  2. Boersma-Vreugdenhil GR, Blood, 15, 101 (2003)
  3. Chng W.J., Glebov O., Bergsagel P.L., Kuehl W.M., Genetic events in the pathogenesis of multiple myeloma, 10.1016/j.beha.2007.08.004
  4. Yang Y, Einstein J Biol Med, 23, 2 (2007)
  5. Boersma-Vreugdenhil Gienke R., Kuipers Jeroen, van Stralen Esther, Peeters Ton, Michaux Lucienne, Hagemeijer Anne, Pearson Peter L., Clevers Hans C., Bast Bert J. E. G., The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint, 10.1111/j.1365-2141.2004.05050.x
  6. van Noort Mascha, Meeldijk Jan, van der Zee Ruurd, Destree Olivier, Clevers Hans, Wnt Signaling Controls the Phosphorylation Status of β-Catenin, 10.1074/jbc.m111635200
  7. Sieweke Michael H, Tekotte Hildegard, Frampton Jonathan, Graf Thomas, MafB Is an Interaction Partner and Repressor of Ets-1 That Inhibits Erythroid Differentiation, 10.1016/s0092-8674(00)81081-8
  8. Chang H., Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma, 10.1182/blood-2005-01-0033
  9. Hurt Elaine M, Wiestner Adrian, Rosenwald Andreas, Shaffer A.L, Campo Elias, Grogan Tom, Bergsagel P.Leif, Kuehl W.Michael, Staudt Louis M, Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma, 10.1016/s1535-6108(04)00019-4
  10. Rasmussen Thomas, Knudsen Lene Meldgaard, Dahl Inger Marie S., Johnsen Hans Erik, C-MAF Oncogene Dysregulation in Multiple Myeloma: Frequency and Biological Relevance, 10.1080/1042819031000111035
  11. Trudel S., The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells, 10.1182/blood-2005-10-4179
Bibliographic reference Stralen, Ev ; Leguit, R. J. ; Begthel, H. ; Michaux, Lucienne ; Buijs, A. ; et. al. MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients. In: Leukemia, Vol. 23, no. 4, p. 801-3 (2009)
Permanent URL http://hdl.handle.net/2078.1/35654